BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quyn AJ, Steele RJ, Digby J, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes HB, Fraser CG. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: Not FIT for purpose? Ann Clin Biochem. 2018;55:69-76. [PMID: 28661203 DOI: 10.1177/0004563217707981] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Turvill JL, Turnock D, Cottingham D, Haritakis M, Jeffery L, Girdwood A, Hearfield T, Mitchell A, Keding A. The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer. Br J Gen Pract 2021;71:e643-51. [PMID: 33798091 DOI: 10.3399/BJGP.2020.1098] [Reference Citation Analysis]
2 D'Souza N, Delisle TG, Chen M, Benton SC, Abulafi M; NICE FIT Steering Committee . Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study. Br J Surg 2021;108:804-10. [PMID: 33755051 DOI: 10.1093/bjs/znaa132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fraser CG. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges. Surgeon. 2018;16:302-308. [PMID: 29548552 DOI: 10.1016/j.surge.2018.01.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
4 Tsapournas G, Hellström PM, Cao Y, Olsson LI. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy. Scand J Gastroenterol 2020;55:184-92. [PMID: 31906738 DOI: 10.1080/00365521.2019.1708965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Nicholson BD, James T, Paddon M, Justice S, Oke JL, East JE, Shine B. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.Aliment Pharmacol Ther. 2020;52:1031-1041. [PMID: 32677733 DOI: 10.1111/apt.15969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
6 Godber IM, Benton SC, Fraser CG. Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints. J Clin Pathol 2018;71:1041-5. [DOI: 10.1136/jclinpath-2018-205047] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
7 Khan AA, Klimovskij M, Harshen R. Accuracy of faecal immunochemical testing in patients with symptomatic colorectal cancer. BJS Open 2020. [PMID: 32949085 DOI: 10.1002/bjs5.50346] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 McSorley ST, Digby J, Clyde D, Cruickshank N, Burton P, Barker L, Strachan JA, Fraser CG, Smith K, Mowat C, Winter J, Steele RJC. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care. Colorectal Dis 2021;23:1615-21. [PMID: 33064898 DOI: 10.1111/codi.15405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fraser CG. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies. Gastroenterol Hepatol 2019;42:263-70. [PMID: 30459060 DOI: 10.1016/j.gastrohep.2018.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
10 Pin Vieito N, Zarraquiños S, Cubiella J. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis. World J Gastroenterol 2019; 25(19): 2383-2401 [PMID: 31148909 DOI: 10.3748/wjg.v25.i19.2383] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
11 Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Impact of the faecal immunochemical test on colorectal cancer survival. BMC Cancer 2020;20:616. [PMID: 32611328 DOI: 10.1186/s12885-020-07074-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Arasaradnam RP, Brown S, Forbes A, Fox MR, Hungin P, Kelman L, Major G, O'Connor M, Sanders DS, Sinha R, Smith SC, Thomas P, Walters JRF. Guidelines for the investigation of chronic diarrhea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018;67:1380-1399. [PMID: 29653941 DOI: 10.1136/gutjnl-2017-315909] [Cited by in Crossref: 91] [Cited by in F6Publishing: 71] [Article Influence: 22.8] [Reference Citation Analysis]
13 Nicholson BD, James T, East JE, Grimshaw D, Paddon M, Justice S, Oke JL, Shine B. Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK. Frontline Gastroenterol 2019;10:347-55. [PMID: 31656559 DOI: 10.1136/flgastro-2018-101052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Bailey SER, Abel GA, Atkins A, Byford R, Davies SJ, Mays J, McDonald TJ, Miller J, Neck C, Renninson J, Thomas P, Walter FM, Warren S, Hamilton W. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England. Br J Cancer 2021;124:1231-6. [PMID: 33462361 DOI: 10.1038/s41416-020-01221-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Herrero JM, Vega P, Salve M, Bujanda L, Cubiella J. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: A diagnostic tests study. BMC Gastroenterol. 2018;18:155. [PMID: 30359225 DOI: 10.1186/s12876-018-0887-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
16 MacDonald S, MacDonald L, Godwin J, Macdonald A, Thornton M. The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population. Colorectal Dis 2021. [PMID: 34797583 DOI: 10.1111/codi.15994] [Reference Citation Analysis]
17 Laszlo HE, Seward E, Ayling RM, Lake J, Malhi A, Stephens C, Pritchard-Jones K, Chung D, Hackshaw A, Machesney M. Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review. Br J Cancer 2021. [PMID: 34903843 DOI: 10.1038/s41416-021-01653-x] [Reference Citation Analysis]
18 [DOI: 10.1101/2020.08.21.20173534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Digby J, Strachan JA, Mowat C, Steele RJC, Fraser CG. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study. BMC Gastroenterol 2019;19:213. [PMID: 31829141 DOI: 10.1186/s12876-019-1135-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
20 Digby J, Steele RJ, Strachan JA, Mowat C, Anderson AS, Mccann R, Law L, Fraser CG. Do other variables add value to assessment of the risk of colorectal disease using faecal immunochemical tests for haemoglobin? Ann Clin Biochem 2019;56:472-9. [DOI: 10.1177/0004563219839423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]